欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HU/H/0361/001
药品名称LENZETTO 1,53 mg/spray transdermal spray, solution
活性成分
    • estradiol hemihydrate 1.53 mg/dose
剂型Transdermal spray, solution
上市许可持有人Gedeon Richter Plc. Gyömrői út 19-21. 1103 Budapest Hungary
参考成员国 - 产品名称Hungary (HU)
LENZETTO 1,53 mg/adag transzdermális oldatos spray
互认成员国 - 产品名称
    • Germany (DE)
      LENZETTO
    • Denmark (DK)
    • Belgium (BE)
      Lenzetto 1,53 mg/dosis, transdermale spray, oplossing
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
      Lenzetto 1,53 mg Úði til notkunar um húð
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
      LENZETTO
    • Sweden (SE)
    • Norway (NO)
      Lenzetto
    • Finland (FI)
    • Poland (PL)
      Lenzetto
    • Latvia (LV)
      Lenzetto 1,53 mg/izsmidzinājumā transdermāls aerosols, šķīdums
    • Lithuania (LT)
      Lenzetto 1,53 mg/išpurškime transderminis purškalas (tirpalas)
    • Estonia (EE)
      Lenzetto
    • Bulgaria (BG)
      Lenzetto
    • Czechia (CZ)
      LENZETTO 1,53 MG-DÁVKA
    • Romania (RO)
      Lenzetto 1,53 mg/ doză spray transdermic, soluţie
    • Slovakia (SK)
      Lenzetto 1,53 mg/dávka
    • Slovenia (SI)
    • Malta (MT)
      Lenzetto 1.5 mg/spray transdermal spray
    • Croatia (HR)
      Lenzetto 1,53 mg po potisku, transdermalni sprej, otopina
许可日期2015/06/25
最近更新日期2024/01/11
药物ATC编码
    • G03CA03 estradiol
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase